Does BICALUTAMIDE Cause Prostatic specific antigen increased? 322 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 322 reports of Prostatic specific antigen increased have been filed in association with BICALUTAMIDE (Bicalutamide). This represents 7.9% of all adverse event reports for BICALUTAMIDE.
322
Reports of Prostatic specific antigen increased with BICALUTAMIDE
7.9%
of all BICALUTAMIDE reports
18
Deaths
41
Hospitalizations
How Dangerous Is Prostatic specific antigen increased From BICALUTAMIDE?
Of the 322 reports, 18 (5.6%) resulted in death, 41 (12.7%) required hospitalization, and 3 (0.9%) were considered life-threatening.
Is Prostatic specific antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BICALUTAMIDE. However, 322 reports have been filed with the FAERS database.
What Other Side Effects Does BICALUTAMIDE Cause?
Malignant neoplasm progression (352)
Drug ineffective (268)
Fatigue (258)
Prostate cancer (258)
Asthenia (223)
Hot flush (219)
Off label use (171)
Disease progression (169)
Anaemia (164)
Death (164)
What Other Drugs Cause Prostatic specific antigen increased?
ENZALUTAMIDE (3,731)
LEUPROLIDE (2,432)
ABIRATERONE (1,581)
RADIUM RA-223 DICHLORIDE (449)
RELUGOLIX (335)
DOCETAXEL (282)
APALUTAMIDE (251)
DENOSUMAB (220)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (212)
OLAPARIB (176)
Which BICALUTAMIDE Alternatives Have Lower Prostatic specific antigen increased Risk?
BICALUTAMIDE vs BICTEGRAVIR
BICALUTAMIDE vs BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE
BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM
BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
BICALUTAMIDE vs BILASTINE